Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2026HaematologicaOpen Access

Pediatric-inspired therapy and blinatumomab consolidation improve outcomes in young adults with Philadelphia-like acute lymphoblastic leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

IAIbrahim AldossALArthur LiDKDiana Knobler

Discussion

Loading...

Member takes

Overview

Retrospective study reveals improved remission and lower relapse with pediatric-inspired therapy in Philadelphia-like acute lymphoblastic leukemia, indicating superior treatment strategies.

Key Points

  • To evaluate the clinical characteristics and therapeutic outcomes of young adults with Philadelphia-like acute lymphoblastic leukemia treated with pediatric-inspired regimens and targeted consolidations.
  • Retrospectively analyzed N=140 consecutive adult patients with Philadelphia-like acute lymphoblastic leukemia treated at a single institution (median age 33.5 years).
  • Characterized genomic features including CRLF2 rearrangements (85%), IKZF1plus deletions (26%), and JAK mutations (37%).
  • Evaluated outcomes according to treatment approach, with 75% of patients receiving pediatric-inspired regimens.
  • Pediatric-inspired regimens were associated with significantly higher complete remission rates compared to alternative regimens (p=0.034).
  • Patients receiving pediatric-inspired regimens experienced a reduced risk of disease relapse.

Cite This Study

Aldoss et al. (2026) studied this question.

synapsesocial.com/papers/6a9bd4126b95aff0620eb5f7https://doi.org/10.3324/haematol.2026.301486
View Full Paper
Ask AI
Bookmark
Share